Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated with Immune Checkpoint Inhibitor Therapy
Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review
Fingerprint
Entra nei temi di ricerca di 'Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated with Immune Checkpoint Inhibitor Therapy'. Insieme formano una fingerprint unica.